Colour Coded Duplex Ultrasound of Native Arterio-venous Fistula for Haemodialysis With Venous Pressure Measurement Using Controlled Compression Ultrasound as a Predictor for Shunt Maturation in the Early Postoperative Phase

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2010 by University of Zurich.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
University of Zurich
ClinicalTrials.gov Identifier:
NCT01001000
First received: October 22, 2009
Last updated: June 28, 2010
Last verified: June 2010
  Purpose

Prospective observational ultrasound study of native arterio-venous fistula for haemodialysis with venous pressure measurement using controlled compression ultrasound.


Condition Intervention
Renal Insufficiency
Procedure: Ultrasound (Pressure measurement)

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective

Resource links provided by NLM:


Further study details as provided by University of Zurich:

Estimated Enrollment: 40
Study Start Date: October 2009
Estimated Study Completion Date: October 2010
Intervention Details:
    Procedure: Ultrasound (Pressure measurement)
    cut-off value for non maturationg fistulas
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients after creation of a native arterio-venous fistula at the cephalic vein for hemodialysis access

Criteria

Inclusion criteria:

  • Patients after creation of a native arterio-venous fistula at the cephalic vein for hemodialysis access;
  • Informed consent.

Exclusion criteria:

  • Former creation of a native arterio-venous fistula at the same arm;
  • Known upper extremity occlusive arterial disease;
  • Situation when ultrasound examination is not suitable: extreme swelling of the arm, post-operative pain, hematoma, local infections.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01001000

Contacts
Contact: 01 Studienregister MasterAdmins +41 (0)44 255 11 11

Locations
Switzerland
Recruiting
Zurich, Switzerland
Sponsors and Collaborators
University of Zurich
Investigators
Study Director: 01 Studienregister MasterAdmins UniversitaetsSpital Zuerich
  More Information

No publications provided

Responsible Party: Christoph Thalhammer, MD, USZ
ClinicalTrials.gov Identifier: NCT01001000     History of Changes
Other Study ID Numbers: CT-01-2009-USZ
Study First Received: October 22, 2009
Last Updated: June 28, 2010
Health Authority: Switzerland: Ethikkommission

Additional relevant MeSH terms:
Arteriovenous Fistula
Renal Insufficiency
Arteriovenous Malformations
Vascular Malformations
Cardiovascular Abnormalities
Cardiovascular Diseases
Vascular Fistula
Vascular Diseases
Congenital Abnormalities
Fistula
Pathological Conditions, Anatomical
Kidney Diseases
Urologic Diseases

ClinicalTrials.gov processed this record on July 24, 2014